NeoGenomics Inc Cash Flow-to-Debt Ratio
NeoGenomics Inc cash flow-to-debt ratio. NeoGenomics Inc (NEO) has a Cash Flow-to-Debt Ratio of 0.04x as of June 2026, meaning its operating cash flow of $19.96 Million could theoretically repay 0% of its total liabilities ($565.65 Million) in one year. Check NeoGenomics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NeoGenomics Inc (2000–2025)
Cash flow-to-debt ratio of NeoGenomics Inc from 2000 to 2025. Historical debt coverage capacity for NeoGenomics Inc across 26 annual periods. Check NeoGenomics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
NeoGenomics Inc Cash Flow-to-Debt Ratio by Year (2000–2025)
NeoGenomics Inc cash flow-to-debt ratio by year from 2000 to 2025. Year-by-year debt coverage analysis for NeoGenomics Inc. For the full cash flow conversion analysis, see cash flow conversion of NeoGenomics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $5.23 Million | $523.27 Million | ▲ +4.7% |
| 2024 | 0.01x | $7.02 Million | $735.70 Million | ▲ +461.6% |
| 2023 | 0.00x | $-1.95 Million | $739.69 Million | ▲ +97.0% |
| 2022 | -0.09x | $-65.99 Million | $742.01 Million | ▼ -153.4% |
| 2021 | -0.04x | $-26.72 Million | $761.50 Million | ▼ -806.7% |
| 2020 | 0.00x | $1.46 Million | $294.04 Million | ▼ -95.7% |
| 2019 | 0.12x | $23.37 Million | $202.10 Million | ▼ -52.3% |
| 2018 | 0.24x | $44.79 Million | $184.57 Million | ▲ +85.4% |
| 2017 | 0.13x | $18.04 Million | $137.81 Million | ▼ -8.3% |
| 2016 | 0.14x | $21.48 Million | $150.52 Million | ▲ +189.8% |
| 2015 | 0.05x | $6.39 Million | $129.84 Million | ▼ -89.2% |
| 2014 | 0.46x | $9.45 Million | $20.70 Million | ▲ +273.2% |
| 2013 | 0.12x | $2.23 Million | $18.20 Million | ▲ +618.5% |
| 2012 | -0.02x | $-492.00K | $20.86 Million | ▼ -580.4% |
| 2011 | 0.00x | $69.00K | $14.05 Million | ▲ +102.5% |
| 2010 | -0.20x | $-2.05 Million | $10.52 Million | ▲ +5.0% |
| 2009 | -0.21x | $-1.50 Million | $7.30 Million | ▼ -760.9% |
| 2008 | -0.02x | $-138.31K | $5.79 Million | ▲ +96.2% |
| 2007 | -0.63x | $-2.64 Million | $4.20 Million | ▼ -179.2% |
| 2006 | -0.23x | $-693.78K | $3.08 Million | ▲ +48.1% |
| 2005 | -0.43x | $-902.05K | $2.08 Million | ▲ +32.7% |
| 2004 | -0.65x | $-658.13K | $1.02 Million | ▼ -6.2% |
| 2003 | -0.61x | $-532.37K | $874.84K | ▲ +32.9% |
| 2002 | -0.91x | $-384.80K | $424.49K | ▼ -118.1% |
| 2001 | -0.42x | $-77.41K | $186.22K | ▲ +70.7% |
| 2000 | -1.42x | $-177.13K | $125.03K | — |